reports
- GlobalData Healthcare Department
Xenetic Biosciences Inc (XBIO) - Financial Analysis Review
Xenetic Biosciences Inc (XBIO) - Financial Analysis Review Summary Xenetic Biosciences Inc (Xenetic), formerly General Sales & Leasing, Inc., is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of biologic drugs and innovative orphan cancer drugs. The company’s pipeline products include ErepoXen, Virexxa and OncoHist. GlobalData's Xenetic Biosciences Inc (XBIO) - Financial Analysis Review provides a comprehensive insight into the company's history, ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.